- Home
- PDC vs ICCM Comparison
PDC vs ICCM Comparison
Compare PDC & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDC | ICCM |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | Japan | Israel |
| Employees | 20 | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7M | 20.4M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | PDC | ICCM |
|---|---|---|
| Price | $5.10 | $4.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 94.3K | ★ 8.9M |
| Earning Date | 07-01-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.46 | $0.13 |
| 52 Week High | $8.40 | $9.54 |
Technical Indicators
Market Signals| Indicator | PDC | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 53.13 | 55.06 |
| Support Level | $5.92 | $0.62 |
| Resistance Level | $7.90 | $5.69 |
| Average True Range (ATR) | 0.68 | 1.52 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 95.24 | 37.47 |
Price Performance
Historical ComparisonAbout PDC Perpetuals.com Ltd American Depositary Shares
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.